Related Experiment Video
Updated: May 25, 2026
07:59
A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
Published on: October 4, 2019
Artemisinin biosynthesis and its regulatory enzymes: Progress and perspective
1Department of Natural Medicinal Chemistry, Jinan University, Guangzhou, China.
Pharmacognosy Reviews
|January 27, 2012
Summary
Artemisinin, a key anti-malarial compound from Artemisia annua, has a complex biosynthesis pathway. Research focuses on understanding and optimizing this pathway, including key enzymes, to meet global demand.
Area of Science:
- Pharmacology
- Biochemistry
- Medicinal Chemistry
Background:
- Artemisinin is a vital sesquiterpene lactone endoperoxide derived from Artemisia annua.
- It is a cornerstone treatment for malaria, necessitating efficient production methods.
- The biosynthesis pathway of artemisinin has been a subject of extensive research.
Purpose of the Study:
- To review the current progress in understanding artemisinin biosynthesis.
- To discuss the roles and applications of key regulatory enzymes in the pathway.
- To highlight existing knowledge gaps and ongoing scientific debates.
Main Methods:
- Literature review of scientific publications on artemisinin biosynthesis.
- Analysis of research on enzymes like amorpha-4,11-diene synthase, CYP71AV1, and cytochrome P450 reductase.
- Synthesis of information regarding advancements and controversies in the field.
Main Results:
- Identification and characterization of several key enzymes involved in artemisinin production.
- Demonstration of enzyme utilization for enhancing artemisinin content.
- Recognition of persistent knowledge gaps and areas of scientific disagreement.
Conclusions:
- Significant progress has been made in elucidating the artemisinin biosynthesis pathway and its enzymes.
- Further research is crucial to address controversies and optimize artemisinin production for pharmaceutical needs.
- Understanding these pathways is key to improving malaria treatment accessibility.
Related Concept Videos
01:29Amino Acid Biosynthetic Pathways
Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which provide...
01:28Biosynthesis of Nucleic Acids
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...